Takeda Pharmaceutical Pink Sheet Forecast - 20 Period Moving Average

TKPHF Stock  USD 25.12  0.67  2.74%   
The 20 Period Moving Average forecasted value of Takeda Pharmaceutical Co on the next trading day is expected to be 25.84 with a mean absolute deviation of 0.86 and the sum of the absolute errors of 35.16. Takeda Pink Sheet Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Takeda Pharmaceutical's historical fundamentals, such as revenue growth or operating cash flow patterns.
  
A commonly used 20-period moving average forecast model for Takeda Pharmaceutical Co is based on a synthetically constructed Takeda Pharmaceuticaldaily price series in which the value for a trading day is replaced by the mean of that value and the values for 20 of preceding and succeeding time periods. This model is best suited for price series data that changes over time.

Takeda Pharmaceutical 20 Period Moving Average Price Forecast For the 31st of December

Given 90 days horizon, the 20 Period Moving Average forecasted value of Takeda Pharmaceutical Co on the next trading day is expected to be 25.84 with a mean absolute deviation of 0.86, mean absolute percentage error of 0.93, and the sum of the absolute errors of 35.16.
Please note that although there have been many attempts to predict Takeda Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Takeda Pharmaceutical's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Takeda Pharmaceutical Pink Sheet Forecast Pattern

Backtest Takeda PharmaceuticalTakeda Pharmaceutical Price PredictionBuy or Sell Advice 

Takeda Pharmaceutical Forecasted Value

In the context of forecasting Takeda Pharmaceutical's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Takeda Pharmaceutical's downside and upside margins for the forecasting period are 22.94 and 28.75, respectively. We have considered Takeda Pharmaceutical's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
25.12
25.84
Expected Value
28.75
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the 20 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Takeda Pharmaceutical pink sheet data series using in forecasting. Note that when a statistical model is used to represent Takeda Pharmaceutical pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria81.2769
BiasArithmetic mean of the errors 0.497
MADMean absolute deviation0.8576
MAPEMean absolute percentage error0.033
SAESum of the absolute errors35.163
The eieght-period moving average method has an advantage over other forecasting models in that it does smooth out peaks and valleys in a set of daily observations. Takeda Pharmaceutical 20-period moving average forecast can only be used reliably to predict one or two periods into the future.

Predictive Modules for Takeda Pharmaceutical

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Takeda Pharmaceutical. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
22.2125.1228.03
Details
Intrinsic
Valuation
LowRealHigh
18.7821.6927.63
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Takeda Pharmaceutical. Your research has to be compared to or analyzed against Takeda Pharmaceutical's peers to derive any actionable benefits. When done correctly, Takeda Pharmaceutical's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Takeda Pharmaceutical.

Other Forecasting Options for Takeda Pharmaceutical

For every potential investor in Takeda, whether a beginner or expert, Takeda Pharmaceutical's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Takeda Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Takeda. Basic forecasting techniques help filter out the noise by identifying Takeda Pharmaceutical's price trends.

Takeda Pharmaceutical Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Takeda Pharmaceutical pink sheet to make a market-neutral strategy. Peer analysis of Takeda Pharmaceutical could also be used in its relative valuation, which is a method of valuing Takeda Pharmaceutical by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Takeda Pharmaceutical Technical and Predictive Analytics

The pink sheet market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Takeda Pharmaceutical's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Takeda Pharmaceutical's current price.

Takeda Pharmaceutical Market Strength Events

Market strength indicators help investors to evaluate how Takeda Pharmaceutical pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Takeda Pharmaceutical shares will generate the highest return on investment. By undertsting and applying Takeda Pharmaceutical pink sheet market strength indicators, traders can identify Takeda Pharmaceutical Co entry and exit signals to maximize returns.

Takeda Pharmaceutical Risk Indicators

The analysis of Takeda Pharmaceutical's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Takeda Pharmaceutical's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting takeda pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Currently Active Assets on Macroaxis

Additional Information and Resources on Investing in Takeda Pink Sheet

When determining whether Takeda Pharmaceutical is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Takeda Pink Sheet is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Takeda Pharmaceutical Co Stock. Highlighted below are key reports to facilitate an investment decision about Takeda Pharmaceutical Co Stock:
Check out Historical Fundamental Analysis of Takeda Pharmaceutical to cross-verify your projections.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Please note, there is a significant difference between Takeda Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Takeda Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Takeda Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.